Halozyme Therapeutics (HALO) Operating Margin (2010 - 2026)
Halozyme Therapeutics (HALO) operating margin from Jun 30, 2010 to Mar 31, 2026. The current Halozyme Therapeutics (HALO) operating margin is 48.98%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Halozyme Therapeutics (HALO)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | 33.58% | -38.17% |
| 2024 | 54.32% | +33.43% |
| 2023 | 40.71% | +0.45% |
| 2022 | 40.53% | -34.88% |
| 2021 | 62.24% | +15.44% |
| 2020 | 53.91% | N/A |
| 2020 | 0.00% | N/A |
| 2020 | 0.00% | N/A |
| 2020 | 0.00% | -100.00% |
| 2019 | -34.50% | N/A |
| 2019 | 0.00% | N/A |
| 2019 | 0.00% | N/A |
| 2019 | 0.00% | -100.00% |
| 2018 | -45.65% | N/A |
| 2018 | 0.00% | N/A |
| 2018 | 0.00% | N/A |
| 2018 | 0.00% | -100.00% |
| 2017 | 25.58% | N/A |
| 2017 | 0.00% | N/A |
| 2017 | 0.00% | N/A |
| 2017 | 0.00% | -100.00% |
| 2016 | -56.73% | N/A |
| 2016 | 0.00% | N/A |
| 2016 | 0.00% | N/A |
| 2016 | 0.00% | -100.00% |
| 2015 | -20.32% | N/A |
| 2015 | 0.00% | N/A |
| 2015 | 0.00% | N/A |
| 2015 | 0.00% | -100.00% |
| 2014 | -83.69% | N/A |
| 2014 | 0.00% | N/A |
| 2014 | 0.00% | N/A |
| 2014 | 0.00% | -100.00% |
| 2013 | -146.77% | N/A |
| 2013 | 0.00% | N/A |
| 2013 | 0.00% | N/A |
| 2013 | 0.00% | -100.00% |
| 2012 | -126.67% | N/A |
| 2012 | 0.00% | N/A |
| 2012 | 0.00% | N/A |
| 2012 | 0.00% | -100.00% |
| 2011 | -35.37% | N/A |
| 2011 | 0.00% | N/A |
| 2011 | 0.00% | N/A |
| 2011 | 0.00% | -100.00% |
| 2010 | -398.38% | -6.84% |
| 2009 | -427.65% | N/A |
Comparison Halozyme Therapeutics (HALO) operating margin with competitors
Halozyme Therapeutics (HALO) operating margin is 48.98%.